Mark H. Rozenbaum
Impact in
- Epidemiology top 2%
- Pneumonia and Respiratory Infections
- Respiratory viral infections research
- Influenza Virus Research Studies
- Microbiology top 5%
- Bacterial Infections and Vaccines
Papers in
- Epidemiology 45
- Pneumonia and Respiratory Infections 28
- Respiratory viral infections research 15
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 15
- Co-authors
- Maarten J. Postma (36 shared papers)Eelko Hak (9 shared papers)Tjip S. van der Werf (3 shared papers)Marie‐Josée J. Mangen (3 shared papers)Albert Jan van Hoek (3 shared papers)Stefan Vegter (4 shared papers)Elizabeth Begier (7 shared papers)Susanne M. Huijts (2 shared papers)
- Journals
- Infectious Diseases and Therapy (9 papers)Vaccine (8 papers)Expert Review of Vaccines (5 papers)Value in Health (5 papers)The Journal of Infectious Diseases (3 papers)
- Partner nations
- NetherlandsUnited StatesUnited Kingdom
In The Last Decade
Mark H. Rozenbaum
70 papers receiving 1.8k citations
Mark H. Rozenbaum's Hit Papers
Peers
Comparison fields: 5 of 103
- Epidemiology 957
- Microbiology 110
- Infectious Diseases 225
- Health 86
- Hepatology 67
Countries citing papers authored by Mark H. Rozenbaum
This map shows the geographic impact of Mark H. Rozenbaum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark H. Rozenbaum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark H. Rozenbaum more than expected).
Fields of papers citing papers by Mark H. Rozenbaum
This network shows the impact of papers produced by Mark H. Rozenbaum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark H. Rozenbaum. The network helps show where Mark H. Rozenbaum may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark H. Rozenbaum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Underascertainment of Respiratory Syncytial Virus Infection in Adults Due to Diagnostic Testing Limitations: A Systematic Literature Review and Meta-analysis Hit paper breakdown → | 2023 | 106 |
| 2 | 2010 | 105 | |
| 3 | 2015 | 104 | |
| 4 | 2015 | 89 | |
| 5 | 2012 | 85 | |
| 6 | 2021 | 71 | |
| 7 | 2008 | 66 | |
| 8 | 2006 | 63 | |
| 9 | 2012 | 61 | |
| 10 | 2018 | 60 | |
| 11 | 2023 | 55 | |
| 12 | 2011 | 52 | |
| 13 | 2023 | 49 | |
| 14 | 2008 | 47 | |
| 15 | 2010 | 41 | |
| 16 | 2011 | 40 | |
| 17 | 2011 | 34 | |
| 18 | 2021 | 31 | |
| 19 | 2005 | 31 | |
| 20 | 2022 | 30 |
About Mark H. Rozenbaum
Mark H. Rozenbaum is a scholar working on Epidemiology, Molecular Biology, Economics and Econometrics, Infectious Diseases and Microbiology, having authored 75 papers that have together received 1.8k indexed citations. Recurring topics across this work include Pneumonia and Respiratory Infections (28 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (15 papers), Respiratory viral infections research (15 papers), Bacterial Infections and Vaccines (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Viral gastroenteritis research and epidemiology (5 papers), Pharmaceutical Economics and Policy (5 papers) and Parathyroid Disorders and Treatments (5 papers). The work is most often cited by research in Epidemiology (957 citations), Microbiology (110 citations), Infectious Diseases (225 citations), Health (86 citations) and Hepatology (67 citations). Mark H. Rozenbaum has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Maarten J. Postma, Eelko Hak, Tjip S. van der Werf, Marie‐Josée J. Mangen, Albert Jan van Hoek, Stefan Vegter, Elizabeth Begier, Susanne M. Huijts, Cornelis Boersma and Elisabeth A. M. Sanders. Their work appears in journals such as Infectious Diseases and Therapy, Vaccine, Expert Review of Vaccines, Value in Health and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.